shorts can easily cover without effecting the price substantially, if fact they could manipulate it down while they do so, which is why they wouldn't try to cover all at once. these guys are racketeers not given a blink by the SEC. Anything short (no pun intended) of video of Jordan and Jessie dancing or a buyout will not move the needle much. But yes, it is a nice thought.
it's not my drug if that was addressed to me. I have no position in BMRN, I do in SRPT. I do believe there are many unknown mechanisms that are explained later for every drug. Drugs effect different people in different ways for sure, that's one reason there are so many treating one thing.
study had challenges and dystrophin in the real world is a mystery. We often put currently accepted theories as gold standards because we just din't know. Placebo can be very strong but it usually doesn't work over time in terminal disease. We'll see.
this disease rakes up emotion that can trump science when reasonable sample sizes are unavailable to study. In addition the results of some indicate that there is another mechanism in play here than just dystrophin. safety may turn some votes but in a surely to die group many will err on the side of the patient/advocate comments. But this is panel and FDA decision can and does vary at times. Not to mention politics and payola.
Today is panel, not approval, though it does have an impact on the final decision the market reaction will be purely momo. If it gets a positive panel vote than it should be a slam dunk for eteplirsen, safer and more effective to a larger % of participants. this is all market games. BMRN will either soar and fall again if panel is positive. The vote will dictate how much. SRPT will move higher either way: negative vote we're the last man standing (no pun or offense intended); if positive we ride the coattails since there could be no possible way etepirsen could be voted down. well this is the FDA and they've done stranger things for sure.
Q. what the fkk do you want? A. Volume on up days, short covering to the tune of 10%, update on Brazil, Mexico and China, a partner for some of the pipeline, a price/share of at least $13, EU submittal. That's enough for now
no conviction from the market. Options expire. We need some solid news about another country, EU and/or the pipeline. absent that we're stuck. and if the past is still a predictor, even with it someone with a stake or trying to get one will flush the toilet.
really? Most think it's an error for purport but they perhaps are incorrect. perhaps.
great way to give up most of the country to your competitors. And what's up with expanding insurance coverage? Contrave seems to be doing just fine. Eisai is the problem.
From facebook support group. names removed for privacy. You'd think that these real users would be the subject of some advertisment.
THANK YOU B! I went for a checkup yesterday and ALL my labs looked fantastic. My doc called me the "valedictorian of PCOS". HA! I was also told that recent studies have shown that people on Belviq have a long-term lower risk of cardiac trouble. I am so happy with this medicine.
You and 20 others like this.
Its been a life changer for me also!! Me too my cholesterol is down from 250 to 160 yay!!
It feels amazing. Mine went from 400 to 140. From deadly to perfectly safe!!!
Great work. Did it work right away for you or did it take some time?
It worked right away but my scale has moved super slow. I've lost steadily though and never gained. I have PCOS so weight gain aggravates the symptoms. It also makes it hard to lose! Stupid PCOS.
I also have that
lol, use your obvious powerful investigative skills to see who might be real. And perhaps another prediction of the same that mysteriously came true. just lucky I guess.
smuf my friend. Hope you are well. I saw the knee extension kicks. He's lying on his back and generating multiple voluntary contractions. This suggests a two joint muscle is primarily being used in a stretch efficient position and that would be the rectus femoris. Innervated by the posterior branch of the femoral nerve a L3-L4 segmental representation. The entire quad is so innervated so we are regenerating and doing so amazingly quickly. I have to believe the report about the ankle and that would be suggesting some sacral return I but would love to see a video or/and an EMG/NCV test. Jessie would be more remarkable as she was medically unstable and had a longer wait. I haven't seen official reports on bowel/bladder and i consider that a hallmark of success if she too or any of the others have regained control. as far as walking you know better than anyone the challenge, difficulty and energy consumption needed. Given the total picture she probably can be considered doing better than Jordan at this time. truly exciting.
The year update mentioned he was moving his ankle up and down.have you seen a video of this? I have not been able to find one if there is. Thanks for any informed reply.